Domestic Violence, intimate partner abuse, Intimate Partner Violence, Homicide, intimate partner homicide, Health Outcomes, Research, Nurse, Johns Hopkins, Nursing, Pregnancies, Women's Health, Gun Control, Gun Control Laws, Abuse & Trauma, abuse preventio
Jacquelyn Campbell is a national leader in research and advocacy in the field of domestic violence or intimate partner violence (IPV). Her expertise is frequently sought by national and international policy makers in exploring IPV and its health effects on families and communities. Her most recent research in health sequelae has been foundational for the areas of the intersection of HIV and violence against women and how head injuries and strangulation from intimate partner violence can result in undiagnosed and untreated Traumatic Brain Injury. She has consistently advocated for addressing health inequities of marginalized women in this country and globally affected by experiences of violence. She has served as Principle Investigator on 14 federally funded collaborative research investigations through the National Institutes of Health, National Institutes of Justice, Department of Defense, the Department of Justice (Office of Violence Against Women), and Centers for Disease Control to examine intimate partner homicide and other forms of violence against women as well as interventions and policy initiatives to improve the justice and health care system response. This work has paved the way for a growing body of interdisciplinary knowledge about experiences of violence and health outcomes, risk assessment for lethal and near-lethal domestic violence, and coordinated system (justice, social services, and health) responses to address intimate partner violence. Dr. Campbell has published more than 270 articles, 56 book chapters and seven books, in addition to developing the Danger Assessment, an instrument to assist abused women in accurately determining their level of danger. The Danger Assessment is also the basis of the Lethality Assessment Program (MNADV LAP) for first responders to assess risk of homicide of domestic violence survivors and connect those at high risk with domestic violence services. In collaboration with Dr. Nancy Glass, originator of myPlan, a decision aid for IPV survivors, she is leading an NIH-funded cultural adaptation of myPlan for immigrant and indigenous women. Elected to the Institute of Medicine in 2000, Dr. Campbell also was the Institute of Medicine/American Academy of Nursing/American Nurses' Foundation Senior Scholar in Residence and was founding co-chair of the IOM Forum on the Prevention of Global Violence. Other honors include the Pathfinder Distinguished Researcher by the Friends of the National Institute of Health National Institute for Nursing Research, Outstanding Alumna and Distinguished Contributions to Nursing Science Awards, Duke University School of Nursing, the American Society of Criminology Vollmer Award, and being named one of the inaugural 17 Gilman Scholars at Johns Hopkins University. She is on the Board of Directors for Futures Without Violence, is an active member of the Johns Hopkins Women’s Health Research Group, and has served on the boards of the House of Ruth Battered Women's Shelter and four other shelters. She was a member of the congressionally appointed U.S. Department of Defense Task Force on Domestic Violence.
James Hendler, the Director of the Institute for Data Exploration and Applications (IDEA) at Rensselaer Polytechnic Institute is an expert in artificial intelligence and one of the originators of the “Semantic Web.” Hendler currently serves as the chair of the U.S. Technology Policy Committee for the Association of Computing Machinery (ACM) which includes subcommittees on voting and cybersecurity. He is a former member of the U.S. Air Force Science Advisory Board, the former chief scientist of the Information Systems Office at the U.S. Defense Advanced Research Projects Agency (DARPA), and a recipient of the U.S. Air Force Exceptional Civilian Service Medal. In addition to numerous other policymakers and government agencies, including the Department of Defense, Hendler has worked with the White House on the development of Data.gov, the U.S. government’s open data site, as an “Internet Web Expert.” In 2010, Hendler was named one of the 20 most innovative professors in America by Playboy magazine
Dr. Frazier completed a neurosurgical residency at the Johns Hopkins Hospital after earning a medical degree from the Johns Hopkins University School of Medicine and an undergraduate degree magna cum laude from Brown University in Providence, Rhode Island. As a medical student, Dr. Frazier received the Hunterian Medical Student Research Award for his work on interstitial chemotherapy for brain tumors. During his training, Dr. Frazier completed specialized fellowships in neuro-oncology and radiosurgery.
Researchers available to discuss user privacy, diversity, the dark web, data breaches, hacking, robocalls and more during Cybersecurity Awareness Month
In the quest for molecular-level information, molecular-scale tools are a powerful and desirable scientific goal. Our research program is centered on development of a new class of nanofabricated devices based on nanopores. In its simplest form, a nanopore is nothing more than a molecular-sized hole in an insulating membrane. Yet even in this configuration, it is cable of being used to detect and manipulate single molecules. With careful device engineering, it is possible to create powerful sensors for the detection of disease biomarkers at low levels early in the onset of disease or of trace amounts of toxins -- to name two targets. Configured differently, nanopore-based devices can be used to probe intermolecular interactions that underpin biological function -- ranging from testing new pharmaceutical drug candidates to exploring the fundamental biophysics governing processes such as antibody-antigen recognition. Our research is focused on conceiving, fabricating and optimizing the nanopore devices that will make possible these challenging goals. Research Interests include: How do molecules work, and how can we better put them to work for us? Bioanalytical, biophysical, & materials chemistry and nanoscience.
Dr. Patterson’s laboratory works on the development of countermeasures against potential biological weapons. Her group focuses on the development of therapies and vaccines against naturally occurring pathogens that can cause sporadic but lethal outbreaks, and her most recent studies concentrate on hemorrhagic fever viruses. Dr. Patterson has been involved in the development of three vaccines against Ebola and two vaccines against Lassa fever that are undergoing further studies. Her lab utilizes the maximum containment laboratory (BSL-4) at Texas Biomed. Dr. Patterson helped develop a marmoset model used for multiple infectious agents: Ebola virus Marburg virus Lassa fever Eastern Equine Encephalitis virus
Professor of Medicine in the Division of InfectiouUniversity of California, Los Angeles (UCLA), Health Sciences
Sexually Transmitted Disease, STI, HIV, AIDS, Public Health, Global Health, Infectious Disease
Dr. Jeffrey Klausner is an expert in infectious disease prevention and control. He is a frequent advisor to the Centers for Disease Control and Prevention and the World Health Organization (WHO). From 1998-2009, Klausner was a deputy health officer, director of STD prevention and control services at the San Francisco Department of Public Health and from 2009-2011 was branch chief for HIV and TB at the Centers for Disease Control, South Africa. Dr. Klausner research interests are in applied epidemiology and the prevention and control of infectious diseases of public health importance like HIV, STDs, TB and cryptococcus. Dr. Klausner has a particular interest in the use of technology—information, digital, and laboratory—to facilitate access to treatment for disadvantaged populations. Dr. Klausner has been funded by the NIH, CDC, private pharmaceutical and test manufacturers to study the benefits of new ways to find and treat infectious diseases. He has been a leading advocate in the use of medical male circumcision for HIV and STD prevention.
Assistant Professor, PsychologyThe Institute for Integrative Health and Rowan University
Mindfulness, Mindfulness Based Stress Reduction, Meditation, Inflammation, Psychology, Mindfulomics
Jeff Greeson, PhD, is a Fellow at the Institute for Integrative Health and an Assistant Professor of Psychology at Rowan University in New Jersey. He received his B.A. in Psychology from Swarthmore College, a Masters in Biomedical Chemistry from Thomas Jefferson University, and his Ph.D. in Clinical Psychology from the University of Miami. He completed his clinical internship and postdoctoral fellowship at Duke University Medical Center and was on the faculty at Duke from 2006-2014. Prior to joining Rowan, Dr. Greeson served as Assistant Professor in Clinical Psychology at the University of Pennsylvania, Perelman School of Medicine. Through the Institute for Integrative Health, Greeson is conducting research to understand how mindfulness, as a self-care practice, can reduce the risk of stress-related illness and promote integrative health. A small handful of recent clinical studies have shown that mindfulness meditation can modify gene expression in immune cells, opening the door to a new field of scientific inquiry that Greeson calls “mindfulomics.” This new field, however, is complicated by the fact that mindfulness is at once a state, a trait, and a skill that one can develop through practice, like meditation or yoga. Therefore, to advance our understanding of the impact of mindfulness at the level of biology and our genes, Greeson is examining the following research questions: 1. What pattern of genes are engaged in state mindfulness, when people meditate compared to when they are stressed or just resting quietly? 2. What pattern of genes corresponds to "high" vs. "low" levels of trait mindfulness, measured by scores on a standardized questionnaire? 3. What combination of genes are engaged in a successful treatment response to mindfulness training, and does this genetic pattern correlate to health outcomes, such as psychological well-being, sleep, and objective health measures like blood pressure and inflammation? To view Greeson’s published research articles, please visit: https://www.ncbi.nlm.nih.gov/pubmed/?term=jeffrey+greeson. https://www.researchwithnj.com/en/persons/jeffrey-greeson/publications/ https://scholar.google.com/citations?user=DTEwIR8AAAAJ&hl=en&oi=ao
McCune has written widely on issues relating to masculinity, particularly black masculinity, as well as queer studies, sexuality theory, critical race theory, performance studies and popular culture. His book, “Sexual Discretion: Black Masculinity and the Politics of Passing” (University of Chicago Press, 2014), examines the lives of African-American men who have sex with men while maintaining a heterosexual lifestyle in public.
Jeffrey Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences where he oversees the company’s research, education, and clinical programs and leads efforts focused on bridging the gap between genetic science and clinical application. Dr. Shaman brings years of experience in advising cross-functional teams together with his scholarship in genetics, pharmacology, stem cells, and clinical laboratory operations. Along with the CEO, he forges strategic partnerships with worldwide companies, laboratories, academic institutions, public/private self-insured companies, and federal, state, and regional healthcare and employee systems. Dr. Shaman supports a team of scientists dedicated to precision medicine and who actively research, publish, and present findings in top-tier peer-reviewed journals. He is passionate about educating people from all backgrounds about the power of genetics and pharmacogenomic testing that is integrated with patient health history and clinical decision-support to proactively promote better health. Dr. Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell & Developmental Biology. Dr. Shaman held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation.
I balance cutting-edge fieldwork with analysis of global ecological data to examine how human changes to fire patterns are encouraging forest-savanna transitions, degrading ecosystems and increasing greenhouse gas emissions. Together with an international community of collaborators, I work across disciplines and scales—from individual organisms to entire ecosystems.
Professor Guzmán is a linguistic and medical anthropologist. Her present research focuses on how Latinx immigrant farmworkers in New York talk about mobility, vulnerability, and well-being. Guzmán has also conducted research on medical interaction in Chile and the United States.
Glioblastoma, Fanconi Anemia, HIV, Inherited immunodeficiencies, non-malignant bone marrow failure, Genetic Disorders, portable gene therapy, Gene Therapy, Health Disparities, Blood Stem Cells, Hematopoietic Stem Cells, Global Health, Gene Editing, CRISPR,
Dr. Jennifer Adair is developing gene therapies that safely fine-tune the DNA sequences of blood stem cells to treat genetic disorders, HIV and cancers. Gene therapy — the editing of our DNA to treat disease — is a clinical reality today, but only in a handful of rich countries. As the treatment process stands right now, it depends almost entirely on highly engineered viruses made in high-tech, multimillion-dollar facilities. However, Dr. Adair’s goal is to develop a safe, cost-effective, less invasive and clinically relevant process for gene editing that takes place entirely with the body of a patient – and one that can be accessible to patients worldwide. To help reach this goal, she and colleagues have developed a technology for portable gene therapy. Lab tests show the technology can produce genetically modified blood stem cells that are at least as good as those manufactured in highly specialized clean rooms, requiring less than half the staff. In 2019, she and colleagues published in Nature Materials, a proof-of-principle laboratory study showing, for the first time, that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. The findings raise the possibility that gold could be a key to making gene therapy for HIV and other blood disorders more accessible – with the golden nanoparticles potentially helping to make emerging, high-tech treatments accessible and affordable worldwide. Dr. Adair is an assistant member of the Clinical Research Division at Fred Hutch. She is a research assistant professor of medical oncology at the University of Washington School of Medicine.
Dr. Jennifer Nelson is a United States historian and professor at the University of Redlands with an emphasis in women’s history. Her dissertation became her first book, Women of Color and the Reproductive Rights Movement (NYU Press 2003). Her second book, More Than Medicine: A History of the Women’s Health Movement (NYU Press 2016), extended her research on the feminist and women’s health movements in the United States. She also co-edited with Barbara Molony a volume on transnational feminism, Women’s Activism and “Second Wave” Feminism: Transnational Histories. Nelson has published articles in a variety of women’s history, medical history, and women’s studies journals on the subject of reproductive rights, women’s health, and social justice movements. Her first article on the feminist abortion rights movement in Mexico, “Abortion Rights and Human Rights in Mexico,” in Tanya Saroj Bakhru, ed. Reproductive Justice and Sexual Rights: Transnational Perspectives, was published this year (Routledge 2019). She is currently working on a book-length project on the movements for and against legal abortion in Mexico.
Chang's work focuses on the therapy resistance of cancer stem cells, which has led to several publications and international presentations. Her clinical research aims to evaluate novel biologic agents in breast cancer patients. Chang has worked in the field of tumor-initiating cells for more than 10 years. After her discovery that tumor-initiating cells are chemo-resistant, and that targeting the EGFR/HER2 pathway can decrease this subpopulation, Chang played a key role in demonstrating some of the limitations and mechanisms of tumor-initiating cells. Her work is now focused on the mechanisms that regulate TICs, as well as initiating and planning clinical trials that target this critical tumor initiating subpopulation. She is also interested in characterizing the cross-talk between these different pathways that may lead to mechanisms of resistance, and has identified some of the chief regulatory pathways involved in TIC self-renewal. She is a world-renown clinical investigator, credited as one of the first to describe intrinsic chemo-resistance of tumor-initiating cells.
Jeremy Grace has been a member of the Geneseo faculty since 2000. He is also the coordinator of the International Relations program. He is a lecturer of international relations and director of the IR program at SUNY Geneseo. He received his M.A in International Affairs from American University in Washington DC in 1995. Prior to joining the Geneseo faculty in 2000, he worked for four years designing democratization and elections programs with the Organization for Security and Cooperation in Europe (OSCE) and International Organization for Migration (IOM) in Bosnia and Herzegovina, Kosovo, and East Timor. He has published studies and discussion papers for the IOM, IFES, and the World Bank, and served as Senior Advisor to the IOM Political Rights and Enfranchisement System Strenthening project aimed at protecting the political rights of refugees and conflict-forced migrants. As part of the project, he has provided technical assistance related to peacebuilding, refugees, and democratization to national governments and international organizations through field assessments to Kosovo, Liberia, Uganda, Nepal, and Afghanistan, among others.
My research is centered on understanding and explaining how people make conservation-related judgments and decisions, and the intersection of such judgments with conservation policy. I am particularly interested in how people make decisions related to the conservation of wildlife, and the origins of resource-related conflicts, especially those that involve wildlife. Much of my recent work is focused on understanding judgments and behaviors concerning large carnivores. Natural resources-related values, attitudes, behaviors Natural resources conflicts Wildlife management and policy Human-wildlife conflict
Professor & Senior VP- Neuroscience Drug DiscoverySanford Burnham Prebys Medical Discovery Institute
Neuroscience, Alzheimer's Disease, Multiple Sclerosis (MS), Parkinson's Disease